ATE386824T1 - Verfahren zur virusproduktion - Google Patents

Verfahren zur virusproduktion

Info

Publication number
ATE386824T1
ATE386824T1 AT03746051T AT03746051T ATE386824T1 AT E386824 T1 ATE386824 T1 AT E386824T1 AT 03746051 T AT03746051 T AT 03746051T AT 03746051 T AT03746051 T AT 03746051T AT E386824 T1 ATE386824 T1 AT E386824T1
Authority
AT
Austria
Prior art keywords
virus
cells
temperature
culture
sub
Prior art date
Application number
AT03746051T
Other languages
English (en)
Inventor
Liangzhi Xie
Charles Goochee
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE386824T1 publication Critical patent/ATE386824T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03746051T 2002-03-29 2003-03-27 Verfahren zur virusproduktion ATE386824T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36865402P 2002-03-29 2002-03-29

Publications (1)

Publication Number Publication Date
ATE386824T1 true ATE386824T1 (de) 2008-03-15

Family

ID=28791896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03746051T ATE386824T1 (de) 2002-03-29 2003-03-27 Verfahren zur virusproduktion

Country Status (9)

Country Link
US (1) US7344873B2 (de)
EP (1) EP1492891B1 (de)
JP (1) JP4413012B2 (de)
AT (1) ATE386824T1 (de)
AU (1) AU2003226012B2 (de)
CA (1) CA2478901A1 (de)
DE (1) DE60319210T2 (de)
ES (1) ES2299715T3 (de)
WO (1) WO2003085138A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008135230A1 (en) * 2007-05-04 2008-11-13 Baxter International Inc. Two-step temperature profile for the propagation of viruses
JP2013523175A (ja) 2010-04-14 2013-06-17 イーエムディー・ミリポア・コーポレーション 高力価、高純度のウイルスストックの作製方法及びその使用方法
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
CA2829774C (en) 2011-03-14 2019-09-24 National Research Council Of Canada Method of viral production in cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962424A (en) * 1974-01-31 1976-06-08 Recherche Et Industrie Therapeutiques (R.I.T.) Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them
US5618714A (en) 1993-12-15 1997-04-08 Eli Lilly And Company Methods for producing protein C
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
ES2333425T5 (es) 1995-06-15 2012-08-28 Crucell Holland B.V. Sistemas de empaquetado para adenovirus recombinante humano destinados a terapia génica
EP1200622A4 (de) 1999-07-06 2004-12-22 Merck & Co Inc Hiv impfstoff aus einem das gag-gen tragenden adenovirus
AU9456201A (en) 2000-09-15 2002-03-26 Merck & Co Inc Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications

Also Published As

Publication number Publication date
US7344873B2 (en) 2008-03-18
DE60319210T2 (de) 2009-02-12
JP2005521423A (ja) 2005-07-21
AU2003226012A1 (en) 2003-10-20
US20050176146A1 (en) 2005-08-11
JP4413012B2 (ja) 2010-02-10
ES2299715T3 (es) 2008-06-01
CA2478901A1 (en) 2003-10-16
EP1492891A4 (de) 2005-08-24
DE60319210D1 (de) 2008-04-03
EP1492891A1 (de) 2005-01-05
WO2003085138A1 (en) 2003-10-16
EP1492891B1 (de) 2008-02-20
AU2003226012B2 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
NO20080001L (no) Fremgangsmate til fremstilling av av 1,3-propanediol fra glycerol, et biprodukt fra fremstilling av biodiesel
HK1080507A1 (en) Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
SG161210A1 (en) Methods for expression and purification of recombinant human growth hormone
DK1268748T3 (da) Fremgangsmåde til fremstilling af adenovirale vektorpopulationer
JP2008543338A5 (de)
PL1664318T3 (pl) Mikroorganizm wytwarzający L-aminokwas i sposób wytwarzania L-aminokwasu
DK0960944T3 (da) Forbedret produktion af taxol og taxaner fra cellekulturer af taxus-arter
JP2009536830A5 (de)
RU2009130630A (ru) Способ получения мезенхимной клетки, способ получения зуба и мезенхимная клетка для формирования зуба
DE60030988D1 (de) Verfahren zur Herstellung Von L-Aminosäuren durch Erhöhung des zellulären NADPH
HK1080111A1 (zh) 為研究、臨床眼晴表面移植和組織工程的應用而生長人類結膜組織等同物的方法
ATE326523T1 (de) Verfahren zur fermentativen herstellung von l- methionin
EA199700004A1 (ru) Усиленная аккумуляция трегалозы в растениях
WO2003010304A3 (de) Verfahren zur herstellung isolierter zellkulturen, kulturmedium zur kultivierung von zellkulturen und zellkultur
EP1619245A4 (de) Verfahren zur herstellung von knorpelzellen zur transplantation
ATE386824T1 (de) Verfahren zur virusproduktion
WO2008002329A3 (en) Isolation and expansion of animal cells in cell cultures
EA200800711A1 (ru) Способ культивирования микроорганизмов
DK1212448T3 (da) Fremgangsmåde til fremstilling af exopolysaccharider
CN102893866A (zh) 一种草莓根尖脱毒与组培方法
SE0003958D0 (sv) Method for growth of microorganisms
EP1517987A4 (de) Lungenzellen von baumwollratten zur virenkultur
ATE275329T1 (de) Verfahren zur herstellung transgener pflanzen unter verwendung von apikalspriessenspitzen
DE502006005197D1 (de) Mikroorganismen burkholderia rhizoxina, neue endosymbionten aus rhizopus sp. und verfahren zur herstellung von rhizoxin und / oder rhizoxin-derivaten unter verwendung dieser mikroorganismen
CN104920210A (zh) 一种简易高效的牡丹试管苗生根方法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties